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CLINICAL LETTER
Lamin A/C Missense Mutation R216C Pinpoints 
Overlapping Features Between Brugada 
Syndrome and Laminopathies
Annarita Armaroli, MD, PhD; Cristina Balla, MD, PhD; Cecilia Trabanelli, BS, PhD; Rita Selvatici, BS, PhD;  
Alessandro Brieda, MD; Elisabetta Sette, MD; Matteo Bertini, MD; Donato Mele, MD; Mauro Biffi, MD;  
Gianluca Calogero Campo, MD; Roberto Ferrari, MD, PhD; Alessandra Ferlini, MD, PhD; Francesca Gualandi , MD, PhD
A 31-year-old man experienced at-rest cardiac arrest. After successful resuscitation, the baseline ECG demonstrated sinus rhythm with concave ST seg-
ment elevation in right precordial leads (V1–V3) followed 
by a negative and symmetrical T-wave. Neither coro-
nary artery disease nor electrolytes’ imbalances were 
detected. In the following days, ECG showed a sponta-
neous type 1 Brugada ECG pattern (Figure [A1]), more 
evident with right precordial leads in II and III intercostal 
spaces. Transthoracic echocardiography (Figure [A2]) 
failed to show any cardiomyopathy. Cardiac MRI showed 
normal chambers dimension, wall thickness, volume, and 
function (left ventricular end diastolic volume, 67.7 mL/
m2; IVS, 1 cm; left ventricular end fraction, 59.7%). Late 
gadolinium enhancement sequences were negative; adi-
pose and fibrous tissue infiltration were excluded.
The patient was implanted with a transvenous single 
chamber cardioverter defibrillator (Medtronic). Several 
appropriate ICD interventions on VT and ventricular fibril-
lation were recorded in the following years.
Family history (Figure [B]) was positive for sudden car-
diac death: the maternal grandfather died at age 45 years, 
a II degree maternal cousin died during sleep at age 40 
years. The proband’s mother showed a first degree atrio-
ventricular block (PR interval=280 ms) and right bundle 
branch block (Figure [A3]). A neurological examination in 
the index case and his mother was negative and creatine 
phosphokinase levels were normal in both.
Informed written consent was obtained from all family 
members. Study was approved by the Local Ethics Com-
mittee (152/2013/O/Oss, June 1, 2013). Molecular 
genetic analysis was performed by next generation 
sequencing using PED MASTR Plus assay comprising 
52 cardiac electrical disorders related genes, SCN5A 
included (www.agilent.com).
The c.646C>T variation in exon 4 of Lamin A/C 
(p.R216C) was identified. The minor allele frequency in 
gnomAD is 0.000007080 (https://gnomad.broadinsti-
tute.org/). MLPA analysis of SCN5A was negative.
The nonconservative amino acid substitution p.R216C 
is located in the coiled 1B domain, critical for lamin 
assembly (Figure [C]). In silico prediction tools describe 
it as possibly pathogenic. The variant has been reported 
in three patients with AV-block and atrial fibrillation/VF1,2 
and in 36 subjects belonging to a large white kindred, 
associated to low penetrance and a mild phenotype.3 
Same-site variants have been reported (R216H, R216L) 
with very low population frequency (<0.00003) and clas-
sified as of uncertain significance. Missense variants in 
nearby residues (L215P, L215V, K219N, K219T, R220C, 
R220G) have been described in association with cardiac 
or neuromuscular phenotypes (https://www.ncbi.nlm.
nih.gov/clinvar). Cascade genetic analysis identified the 
p.R216C variant in proband’s mother and in proband’s 
uncle (III2) associated with first degree atrioventricular 
block and left anterior hemiblock at ECG. His 41 years 
old son (IV3), also carrier of the mutation, showed inter-
mittent second degree type 1 atrio-ventricular block and 
Brugada type 2 ECG (Figure [A4]).
To our knowledge, this is the first time in which Bru-
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In our patient, the clinical picture of BrS is not linked to 
a SCN5A mutation. On the other hand, he had no evidence 
of a cardiac conduction system disease, therefore, had no 
markers of a LMNA-related disease. On the contrary, all 
other family members who carried the p.R216C LMNA 
mutation showed, although mild, signs of conduction dis-
turbances supporting a functional effect of the mutation.
Recently published papers have documented INa 
currents alterations in cells carrying LMNA gene muta-
tions; in particular, Salvarani and co-workers demon-
strated a direct interaction between Lamin A/C protein 
and SCN5A gene promoter in induced pluripotent stem 
cell K219T LMNA-mutated derived cardiomyocytes. A 
considerable reduction in SCN5A expression in cardiac 
cells due to epigenetic inhibition was shown.4 Notably, 
SCN5A is the strongest BrS gene and the sodium cur-
rent perturbation is considered as the main pathogenic 
mechanism. In this context, our case represents a first 
phenotypic proof of concept of the direct LMNA-SCN5A 
interaction. As counterpart, the possible occurrence of 
structural alteration of the right ventricular outflow tract 
in BrS is emerging. Nademanee et al5 reported fibro-fatty 
replacement of the right ventricular outflow tract in both 
autoptic and in vivo collected cardiac samples from BrS 
patients. However, any cardiac abnormality was evident 
at ecocardiography and/or cardiac magnetic resonance 
imaging on the same patients suggesting that BrS pat-
tern could be a very early sign of a structural disease.
Mutations in desmosomal genes, associated to 
arrhythmogenic cardiomyopathy, have also been 
described in BrS patients, underlining the overlapping 
of the 2 diseases.6 Notably, LMNA gene mutations have 
been associated to arrhythmogenic cardiomyopathy. The 
identification of a known pathogenic LMNA gene muta-
tion in a classic BrS phenotype, as in our patient, further 
reinforces the idea that BrS could be caused by or could 
masquerade an occult cardiomyopathy.
Although extensive gene panel analysis has been per-
formed the possibility of the coexistence in our case of 
another mutation related to Brugada pattern susceptibil-
ity could not be definitively ruled out.
In conclusion, we propose BrS as part of the laminopa-
thies spectrum, and we suggest LMNA gene screening in 
BrS patients to gain further evidence supporting this view.
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Figure. ECGs of the proband and his affected relatives (mother and a cousin), proband's echocardiographic images and family 
tree, and the schematic representation of LMNA/C protein structure with R216C mutation position.
A1, Proband’s ECG showing a slightly prolonged PR interval and a typical type 1 Brugada pattern in lead V1 and V2.A2, Bidimensional long-
axis (left) and short-axis (right) parasternal echocardiographic images showing normal biventricular dimension. A3, Proband’s mother ECG 
showing a AVB-I with a PR interval of 280 ms and a right bundle branch block with a QRS of 150 ms. A4, Proband’s cousin ECG showing 
type 2 Brugada pattern, first degree AVB (PR=240 ms). B, Family tree: II1: Proband’s grandfather, †SCD 45 y; III1: proband’s mother, 
AVB+RBBB; III2: proband’s uncle, first degree AVB+LAH; IV1: proband’s cousin, †SCD 40 y; IV2: proband, CA 31 y, Brugada type 1 ECG 
pattern; IV3: proband’s first cousin, second degree type 1 AVB, Brugada type 2 ECG pattern. C, Schematic representation of Lamin A and C 
proteins. R216C location in the coil1B domain (arrow). AVB indicates atrioventricular block; CA, cardiac arrest; LAH, left anterior hemiblock; 
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